For the first time, a successful cornea transplant has “restored a patient’s eyesight” (goodnewsnetwork.org). A North Carolina company worked tirelessly, with the assistance of 3D printing technology and human eye cells, to create an effective cornea for struggling patients. Never before has a lab created an aspect of the eye that helped restore vision to a previously blind person.
Explaining the science, Dr. Michael Mimouni, the operating doctor stated, “the implant is designed to match the optical clarity, transparency and bio-mechanical properties of a native cornea.”
Precise Bio, the company behind the groundbreaking technology, claims, “[the] robotic bio-fabrication approach could potentially turn a single donated cornea into hundreds of lab-grown grafts” (fiercebiotech.com). Completely altering the technology behind procedures for patients struggling with blindness, the technology and operations developed by Precise Bio could plausibly help recover millions of patients. According to the Center for Disease Control, “approximately 7 million people in the United States have vision impairment, this includes 1 million with blindness” (cdc.gov).
Exclaimed Dr. Mimouni regarding the operation, “It was an unforgettable moment—a glimpse into a future where no one will have to live in darkness because of a shortage of donor tissue” (fiercebiotech.com).
The company announced that “top-line results” from extensive studies on the technology will be available by the end of 2026.
Anthony Atala, co-founder of Precise Bio and director of the Wake Forest Institute for Regenerative Medicine, stated, “this is a defining moment for the future of regenerative medicine, PB-001 has the potential to offer a new, standardized solution to one of ophthalmology’s most urgent needs—reliable, safe, and effective corneal replacement.”
Overall, this potentially life changing solution to a problem plaguing millions across the globe could thoroughly alter the way the healthcare system looks at eyecare technology.